THE SUMMIT

for

Psychedelic Public Health 

WHY A SUMMIT

A Gathering of Global Experience & Expertise, with Community, Indigenous, Practitioner, Scientific, Public Servant representation to:

Build a strong foundation addressing social determinants of health by centering equity, safety, community, Indigenous people & knowledge, race & gender

Ensure ethical, effective research and action 

Catalyze collaboration that connects research, communities, policy and funding

Amplify and accelerate community and population-level psychedelic benefits

A High Impact Approach

Inclusive In-person invitational for bridge-building; live-streaming for global participation

Equity-driven Equally centering Indigenous, community, academic, and practitioner expertise

Efficient & Actionable Advance groundwork to set the foundation for real-time decision-making

Restorative Setting principles of practice with Indigenous and War on Drugs-impacted communities  

Disseminated Summit decisions will be published and accessibly distributed

Summit deliverables

Summit participants will:

Set Parameters for a New Field 

Define Psychedelic Public Health (PPH) and core framework 

Identify PPH’s community and population-level approaches 

Mechanize how PPH addresses social determinants and root causes 

Set standards for engagement with Indigenous people, knowledge, traditions

Establish Principles of Practice         

Core ethics, ethos, and commitments

Issue a Working Glossary                        

Interdisciplinary collaboration

Advance Research & Action Agenda

Priorities to accelerate collaboration and funding

Cultivate a Global Network                              

Momentum through a global psychedelic public health association - Summit participants as charter members

Build a Movement                                                   

Disseminate Summit work through peer-reviewed articles and position statements for uptake in other agencies; generate media assets for press coverage, social media, and film

Who Plans to Join

A Growing List:

  • Stef Bertozzi: Faculty and Dean (former), UC Berkeley School of Public Health and Collaborative for the Economics of Psychedelics; Bill & Melinda Gates Foundation's Global Health Program (former); UNAIDS, World Health Organization (former)

  • Natalie Brender, Policy Director, Canadian Public Health Association

  • Rielle Capler: Faculty, University of British Columbia, School of Population & Public Health; Board Co-Chair, MAPS, Canada; Co-Founder, Association of Canadian Cannabis Retailers

  • Shannon Dames: Faculty and Investigator, Roots to Thrive, Psychedelic-Assisted Therapy Certificate, and Naut sa Mawt Centre for Psychedelic Research, Vancouver Island University

  • Charlotte Duerr James: Founder, Psychedelic Liberation Training; Guide

  • Brian Emerson: Deputy Provincial Health Officer, Ministry of Health, British Columbia (former), The Expert Advisory Group on Safer Supply; Consultant, Shaw

  • Mark Haden: Faculty, University of British Columbia, School of Population & Public Health, Executive Director, MAPS, Canada (former); Clinical Supervisor of Psychedelic Treatment, Qi Integrated Health; VP of Business Development, Clearmind Medicine

  • Pamela Kryskow: Medical Lead and Researcher, Roots to Thrive, Naut sa Mawt Center for Psychedelic Research, and Psychedelic-Assisted Therapy Certificate, Vancouver Island University; Board Chair Psychedelic Association of Canada

  • Philippe Lucas: Director of Research and Access, MAPS; co-founder Victoria Association of Psychedelic Studies; Board, MAPS Canada; PI/Co-PI for Canadian and Global Psychedelic Survey

  • Veronica Magar: Office of the Director General, World Health Organization (former)

  • Geraldine Manson: Elder in Residence, Naut sa Mawt Center, Vancouver Island University; Roots to Thrive

  • Elliott Marseilles: UC Berkeley Collaborative for the Economics of Psychedelics, School of Public Health

  • Kristin Nash: Co-Founder, Coalition for Psychedelic Safety and Education

  • Taita Luis Alfonso Pazos Alegría: Traditional healer; Interdisciplinary Health Sciences Group, Medellín

  • Marlena Robbins: Indigenous Science Student Fellow, Center for the Science of Psychedelics, doctoral candidate, UCB School of Public Health

  • Pedro Teixeira: Faculty, University of Lisbon, Human Kinetics, Behavioral Psychedelics; Director National Physical Activity Promotion Program, Portuguese Ministry of Health (former); Founder www.safejourney.pt; Research Director, Synthesis Institute (former)

  • Gerald Thomas: Director, Legal Substances & Problem Gambling Policy & Prevention, Ministry of Health, British Columbia

  • Ken Tupper: Faculty, University of British Columbia’s School of Population and Public Health, University of Victoria School of Child and Youth Care; Board, MAPS Canada and Wasiwaska Research Centre, Brazil

  • Stacey Wallin, CEO Psychedelic Safety Institute

  • Missi Wooldridge, Adjunct Professor & Subject Matter Expert (SME) State University of New York College at Potsdam; Consultant Healthy NightLife